Unichem outlines manufacturing plan for generic Hyzaar
Unichem Laboratories Limited has confirmed it will make its generic version of Hyzaar for the US market at three plants in India.
The Mumbai-headquartered firm said it will make the active pharmaceutical ingredients (API) - losartan potassium and hydrochlorothiazide – at its facilities in Pithampur, Madhya Pradesh and Roha, Maharashtra.
Unichem also confirmed in a Bombay Stock Exchange (BSE) filing that it will make the finished formulation of the drug – which is a version of Merck & Co’s blood pressure pill - at its manufacturing facility in Ghaziabad, Uttar Pradesh.
The US Food and Drug Administration (FDA) approved Unichem’s version of the drug earlier this week.
